Affinity Asset Advisors’s Cullinan Oncology CGEM Stock Holding History

Affinity Asset Advisors’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.1M	Sell	781,260 -1,150,846	-60%	-$14.8M	0.65%	46
2025 Q4	$20M	Buy	1,932,106 +1,668,289	+632%	+$15M	1.44%	27
2025 Q3	$1.56M	Hold	263,817	–	–	0.15%	79
2025 Q2	$1.99M	Hold	263,817	–	–	0.29%	56
2025 Q1	$2M	Hold	263,817	–	–	0.31%	68
2024 Q4	$3.21M	Hold	263,817	–	–	0.5%	49
2024 Q3	$4.42M	Hold	263,817	–	–	0.69%	45
2024 Q2	$4.6M	Buy	263,817 +5,229	+2%	+$111K	0.72%	44
2024 Q1	$4.41M	Sell	258,588 -41,412	-14%	-$640K	0.72%	55
2023 Q4	$3.06M	Buy	+300,000	New	+$2.66M	0.61%	47
2021 Q3	–	Sell	-45,000	Closed	-$1.16M	–	80
2021 Q2	$1.16M	Buy	+45,000	New	+$1.38M	0.55%	49

Other funds holding CGEM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return